Neuropathy, a condition that affects individuals of all ages but is most common in older adults, often causes pain in the ...

Among older adults with classical Hodgkin lymphoma, frontline N-AVD has been found to be highly effective and well-tolerated.

A lymphoma specialist who survived her own tumor surgery helps patients navigate the daunting decisions to be made.

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into ...

Our friends with Essential Neuropathy break down what Neuropathy actually is and how they can pinpoint the problem and find ...

Today we meet Craig. He suffered from neuropathy for 5-7 years. He feared the walker and wheelchair. His balance was very ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA ...